Thyroid cancer has traditionally been difficult to accurately diagnose and re-detect in the case of a recurrence. Why is it so difficult to diagnose and have we made further progress in the ability to better identify the markers of thyroid cancer? Dr. Allan Siperstien of Cleveland Clinic Foundation has published research in the area of finding better markers to identify Thyroid Cancer. Learn more in this interview with Dr. Mark Nolan Hill.
Thyroid Cancer Detection
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Recommended
Details
Presenters
Overview
Thyroid cancer has traditionally been difficult to accurately diagnose and re-detect in the case of a recurrence. Why is it so difficult to diagnose and have we made further progress in the ability to better identify the markers of thyroid cancer? Dr. Allan Siperstien of Cleveland Clinic Foundation has published research in the area of finding better markers to identify Thyroid Cancer. Learn more in this interview with Dr. Mark Nolan Hill.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
0.50 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">CETP inhibition: Lessons from two decades of clinical trials</span></p>
CME/CE Broadcast Replay
Pulmonary Hypertension Management: Practice Trends and Updates
1.00 credits
<p>Pulmonary Hypertension Management: Practice Trends and Updates</p>
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
<p>mIDH Gliomas Explained: Characteristics and Management Strategies</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?